Delirium Treatment With Acupuncture in Internal Medicine Departments
NCT03398928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81
Last updated 2020-09-18
Summary
Delirium frequently occurs in hospitalized older people, and treatment options are limited. Acupuncture has been shown to reduce agitation in the setting of dementia. The investigators will test the hypothesis that it may also assist in treating delirium.
Conditions
- Delirium in Old Age
Interventions
- OTHER
-
Acupuncture
Acupuncture added to usual care
Sponsors & Collaborators
-
Bnai Zion Medical Center
lead OTHER_GOV
Principal Investigators
-
Elad Schiff, M.D. · Bnai Zion Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-14
- Primary Completion
- 2019-12-01
- Completion
- 2020-06-01
Countries
- Israel
Study Locations
More Related Trials
-
Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:
NCT05055895 ·Status: UNKNOWN
-
Ramelteon Prevention of Delirium - RCT
NCT02564939 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Hypoactive Delirium and Outcome Measures
NCT02345902 ·Status: UNKNOWN ·Phase: PHASE3
-
Acupuncture Treatment for Improving Alzheimer's Dementia
NCT04064021 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Trial on Agitation in Alzheimer's Dementia
NCT05543681 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
NCT06417086 ·Status: RECRUITING ·Phase: NA
-
Quetiapine in Prevention of Delirium
NCT05793632 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
NCT06546995 ·Status: COMPLETED ·Phase: PHASE1
-
Pain Perception in Alzheimer's Disease
NCT00192816 ·Status: UNKNOWN
-
Nutritional Therapy for Delirium in Elderly Hospitalized Subjects
NCT05066503 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Nabilone in Alzheimer's Disease
NCT02351882 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
SCI-110 for Alzheimer Disease and Agitation
NCT05239390 ·Status: UNKNOWN ·Phase: PHASE2
-
Vestibular Therapy in Alzheimer's Disease
NCT03799991 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
NCT00940589 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease
NCT05644977 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
NCT06651567 ·Status: RECRUITING ·Phase: PHASE2
-
Cholinesterase Activity and DeliriUm During Critical Illness Study
NCT03098472 ·Status: COMPLETED
-
Effects of a NeuroAD System, for the Treatment of Alzheimer Disease
NCT02166827 ·Status: TERMINATED ·Phase: NA
-
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
NCT04436081 ·Status: UNKNOWN ·Phase: PHASE2
-
Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
NCT00095719 ·Status: COMPLETED ·Phase: PHASE3
-
Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease
NCT03283059 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Melatonin: Sleep Problems in Alzheimer's Disease
NCT00000171 ·Status: COMPLETED ·Phase: PHASE3
-
Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease
NCT03115814 ·Status: UNKNOWN
-
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
NCT06803823 ·Status: RECRUITING ·Phase: PHASE2
-
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
NCT01795339 ·Status: COMPLETED ·Phase: PHASE1